Rechercher des projets européens

Plus de 40 projets européens trouvés

Recherche sur 125080 projets européens

 TERMINÉ 

Early-life stressors and LifeCycle health (LIFECYCLE)

Date du début: 1 janv. 2017, Date de fin: 31 déc. 2021,

Early life is an important window of opportunity to improve health across the full lifecycle. European pregnancy and child cohort studies together offer an unique opportunity to identify a wide range of early life stressors linked with individual biological, developmental and health trajectory variations, and to the onset and evolution of non-communicable diseases. LIFECYCLE will establish the Eur ...
Voir le projet

 19

 TERMINÉ 

EUROlinkCAT: Establishing a linked European Cohort of Children with Congenital Anomalies (EUROlinkCAT)

Date du début: 1 janv. 2017, Date de fin: 31 déc. 2021,

Over 130,000 children born in Europe every year will have a congenital anomaly (CA; birth defect). These CAs, which are often rare diseases, are a major cause of infant mortality, childhood morbidity and long-term disability. EUROCAT is an established European network of population-based registries for the epidemiologic surveillance of CAs. EUROlinkCAT will use the EUROCAT infrastructure to suppor ...
Voir le projet

 25

 TERMINÉ 

Protecting patients with enhanced susceptibility to infections (PRONKJEWAIL)

Date du début: 1 sept. 2016, Date de fin: 31 août 2021,

The Microbes in Health and Disease research programme at the University Medical Center Groningen (UMCG) proposes the Doctoral Training Programme PRONKJEWAIL (‘a real gem’) in the field of hospital care and infection. The specific training objective is ‘protecting patients with enhanced susceptibility to infections’. PRONKJEWAIL will recruit 16 international ESRs, who will be trained in research, t ...
Voir le projet

 1

 TERMINÉ 

TIME FOR A CHANGE: An out-of-the-box approach to unravel transitions in depression (TRANS-ID)

Date du début: 1 août 2016, Date de fin: 31 juil. 2021,

Major Depression (MD) is often chronic and characterized by frequent recurrences of symptoms and burden. The need to better understand how and when relevant transitions in symptoms occur is urgent. A seemingly unsolvable scientific problem is the enormous etiological complexity of mental disorders such as MD, involving continuously ongoing gene-environment interactions that act in highly person-sp ...
Voir le projet

 1

 TERMINÉ 

Targeting replication stress recovery pathways in oncology (TENSION)

Date du début: 1 août 2016, Date de fin: 31 juil. 2021,

Genomic instability characterizes tumors, which have no clear ‘oncogenic-driver’ mutation, including triple-negative breast cancers (TNBCs). These patients do not benefit from molecularly targeted treatment and urgently need better treatment options. Increasing evidence points to replication stress as the driver of genomic instability. Since replication stress compromises cell viability, cells hav ...
Voir le projet

 1

 TERMINÉ 

Towards evidence-based tailored implementation strategies for eHealth (ImpleMentAll)

Date du début: 1 janv. 2017, Date de fin: 31 mars 2021,

ImpleMentAll will develop, apply, and evaluate tailored implementation strategies in the context of on-going eHealth implementation initiatives in the EU and beyond. Common mental health disorders account for an alarming proportion of the global burden of disease. Being regarded as an evidence-based psychotherapeutic eHealth intervention, Internet-based Cognitive Behavioural Therapy (iCBT), has th ...
Voir le projet

 19

 TERMINÉ 

The use of computational techniques to Improve compliance to reminders within smartenvironments (REMIND)

Date du début: 1 janv. 2017, Date de fin: 31 déc. 2020,

The aim of this Project is to create an International and Intersectoral network to facilitate the exchange of staff to progress developments in reminding technologies for persons with dementia which can be deployed in smart environments. The focus will be on developing staff and partner skills in the areas of user centered design and behavioral science coupled with improved computational technique ...
Voir le projet

 12

 TERMINÉ 

Towards enduring mouse resources and services advancing research into human health and disease (INFRAFRONTIER2020)

Date du début: 1 janv. 2017, Date de fin: 31 déc. 2020,

The INFRAFRONTIER RI integrates European Mouse Clinics and the European Mouse Mutant Archive with the common goal to ensure access to mouse models for basic research of human health and disease, and to translate this knowledge into therapeutic approaches for the benefit of the European society. The expanded INFRAFRONTIER2020 network, coordinated by the INFRAFRONTIER GmbH, includes 3 SMEs and is st ...
Voir le projet

 33

 TERMINÉ 

Comorbid Conditions of Attention deficit / hyperactivity disorder (CoCA)

Date du début: 1 janv. 2016, Date de fin: 31 déc. 2020,

Understanding mechanisms underlying comorbid disorders poses a challenge for developing precision medicine tools. Psychiatric disorders are highly comorbid, and are among the last areas of medicine, where classification is driven by phenomenology rather than pathophysiology. We will study comorbidity between the most frequent psychiatric conditions, ADHD, mood/anxiety, and substance use disorders, ...
Voir le projet

 17

 TERMINÉ 

Enriched communication across the lifespan (ENRICH)

Date du début: 1 oct. 2016, Date de fin: 30 sept. 2020,

"Speech is a hugely efficient means of communication: a reduced capacity in listening or speaking creates a significant barrier to social inclusion at all points through the lifespan, in education, work and at home. Hearing aids and speech synthesis can help address this reduced capacity but their use imposes greater listener effort. The fundamental objective of the ETN "Enriched communication acr ...
Voir le projet

 8

 TERMINÉ 

European Glaucoma Research Training Program (EGRET)

Date du début: 1 oct. 2015, Date de fin: 30 sept. 2020,

Glaucoma is the most common age-related neurodegenerative eye-disease in western society and one of the four major blinding eye diseases (cataract, macular degeneration, glaucoma, and diabetic retinopathy). Glaucoma is characterized by a progressive loss of retinal nerve cells. The early changes are often unnoticed by the patient. If untreated or detected too late, glaucoma will end up in blindnes ...
Voir le projet

 1

 TERMINÉ 

Defining how environmental factors influence downstream effects of immune-mediated disease risk-SNPs (ImmRisk)

Date du début: 1 sept. 2015, Date de fin: 31 août 2020,

In the last few years genome-wide association studies have revealed thousands of genetic variants associated to immune-mediated diseases, such as rheumatoid arthritis and Crohn's disease. Although it is evident that non-genetic factors can also trigger these diseases, presumably by interacting with the risk SNPs, we do not know what these factors are or how they affect risk-SNPs.I hypothesize that ...
Voir le projet

 1

 TERMINÉ 

HARMONIzation and integrative analysis of regional, national and international Cohorts on primary Sjögren’s Syndrome (pSS) towards improved stratification, treatment and health policy making (HarmonicSS)

Date du début: 1 janv. 2017, Date de fin: 30 juin 2020,

HarmonicSS vision is to create an International Network and Alliance of partners and cohorts, entrusted with the mission of addressing the unmet needs in primary Sjogren Syndrome; working together to create and maintain a platform with open standards and tools, designed to enable secure storage, governance, analytics, access control and controlled sharing of information at multiple levels along wi ...
Voir le projet

 39

 TERMINÉ 

Providing the right care to the right patient with MyeloDysplastic Syndrome at the right time (MDS-RIGHT)

Date du début: 1 mai 2015, Date de fin: 30 avr. 2020,

Myelodysplastic syndromes (MDS) are chronic bone marrow malignancies of the elderly, complicated by severe anaemia. MDS significantly affects quality-adjusted survival and it imposes an increasing financial burden on patients and healthcare (HC) systems. The burden of disease is expected to worsen in the future, given the aging EU population and newly identified MDS cases among those diagnosed wit ...
Voir le projet

 16

 TERMINÉ 

RELapses prevENTion in chronic autoimmune disease: common mechanisms and co-morbidities (RELENT)

Date du début: 1 nov. 2015, Date de fin: 30 avr. 2020,

RELENT is multidisciplinary group of scientists and clinical investigators whose goal is to develop individualized treatment for chronic autoimmune diseases, such as rheumatoid arthritis and vasculitis, that cause considerable mortality and morbidity, both from uncontrolled disease and treatment associated co-morbidities, like infection and malignancy. This requires the need to stratify patients b ...
Voir le projet

 14

 TERMINÉ 

Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia (AML-VACCiN)

Date du début: 1 janv. 2016, Date de fin: 31 mars 2020,

Eradicating minimal residual disease (MRD) in patients with acute myeloid leukaemia (AML) is an area of high unmet medical need. AML is a deadly rare disease that affects both children and adults. Approximately 45% of younger AML patients who are treated will be cured, and in older patients (>60 years of age), 85% will relapse and die within 2 years.Immunotherapy has great potential for treating M ...
Voir le projet

 12

 TERMINÉ 

Enhanced Delivery Ecosystem for Neurosurgery in 2020 (EDEN2020)

Date du début: 1 avr. 2016, Date de fin: 31 mars 2020,

Due to an aging population and the spiralling cost of brain disease in Europe and beyond, EDEN2020 aims to develop the gold standard for one-stop diagnosis and minimally invasive treatment in neurosurgery. Supported by a clear business case, it will exploit the unique track record of leading research institutions and key industrial players in the field of surgical robotics to overcome the current ...
Voir le projet

 9

 TERMINÉ 

Combatting Bacterial Resistance in Europe - Carbapenem Resistance (COMBACTE-CARE)

Date du début: 1 mars 2015, Date de fin: 28 févr. 2020,

Multi-drug resistant Gram-negative bacteria (MDR-GNB): the ultimate challenge!Antibiotic resistance is a global public health concern recently elevated to the top three threats identified by the WHO, and subject of numerous national and international government activities. Although focused strategies have beneficially influenced infection rates due to methicillin resistant Staphylococcus aureus (M ...
Voir le projet

 23

 TERMINÉ 

Intuitive Natural Prosthesis UTilization (INPUT)

Date du début: 1 févr. 2016, Date de fin: 31 janv. 2020,

"INPUT will strive to make the control of complex upper limb prostheses simple, natural and to be used on a daily basis by amputees effortlessly after donning -"don and play". Currently, the most advanced routine prosthetic control on the market is more than 4 decades old, outdated and constitutes the bottle neck to introducing highly dexterous prostheses. The project builds on achievements reache ...
Voir le projet

 7

 TERMINÉ 

Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood (CANCER-ID)

Date du début: 1 janv. 2015, Date de fin: 31 déc. 2019,

Blood-based biomarkers such as Circulating Tumor Cells (CTCs), circulating free tumor DNA (cfDNA) and microRNAs (miRNAs) have the potential to improve the development of personalized medicines for cancer patients. This is of particular importance when biopsies of the primary tumor or metastases are not accessible (e.g. at early disease stages or in minimal residual disease) or possible and the ass ...
Voir le projet

 34

 TERMINÉ 

European Glaucoma Research Training Program-Plus (EGRET-Plus)

Date du début: 1 janv. 2016, Date de fin: 31 déc. 2019,

Glaucoma is the most common age-related neurodegenerative eye-disease in western society and one of the four major blinding eye diseases. If untreated or detected too late, glaucoma will end in blindness, yielding a profound loss of quality of life for the individual and major costs to society. Given the vast complexity of glaucoma, to advance assessment and therapy beyond the current state-of-the ...
Voir le projet

 8

 TERMINÉ 

Personalised Connected Care for Complex Chronic Patients (CONNECARE)

Date du début: 1 avr. 2016, Date de fin: 30 sept. 2019,

The ambition of the CONNECARE consortium is to co-design, develop, deploy, and evaluate a novel smart, adaptive integrated care system for chronic care management. This will save European healthcare organisations huge sums whilst improving patient outcomes. The consortium contains all the necessary partners to ensure success.Based on the concept of 4P medicine, CONNECARE will provide decision supp ...
Voir le projet

 10

 TERMINÉ 

Deciphering the Metabolism of Haematological Cancers (HaemMetabolome)

Date du début: 1 oct. 2015, Date de fin: 30 sept. 2019,

It has long been realised that metabolism is central to cellular development, proliferation and homeostasis. Collectively, aberrations in metabolism are now recognised as a major hallmark of cancer, opening new avenues for personalised medicine. As haematological malignancies are multi-factorial diseases, our main emphasis will be on the integration of biomedical multi-omics data and computational ...
Voir le projet

 4

 TERMINÉ 

Coordinated Research Infrastructures Building Enduring Life-science services (CORBEL)

Date du début: 1 sept. 2015, Date de fin: 31 août 2019,

The social and economic challenges of ageing populations and chronic disease can only be met by translation of biomedical discoveries to new, innovative and cost effective treatments. The ESFRI Biological and Medical Research Infrastructures (BMS RI) underpin every step in this process; effectively joining scientific capabilities and shared services will transform the understanding of biological m ...
Voir le projet

 39

 TERMINÉ 

Unravelling the genetic influences of reproductive behaviour and gene-environment interaction (SOCIOGENOME)

Date du début: 1 juil. 2014, Date de fin: 30 juin 2019,

"This project will be the first to engage in a comprehensive study of the role of genes and gene-environment (GxE) interaction on reproductive behaviour. Until now, social science research has focussed on socio-environmental explanations, largely neglecting the role of genes. Due to unprecedented advances in molecular genetics over the last two decades, for the first time in history we are able to ...
Voir le projet

 2

 TERMINÉ 

Multidisciplinary Approaches to Translational Research In Conduct Syndromes (MATRICS)

Date du début: 1 mars 2014, Date de fin: 28 févr. 2019,

Conduct Disorder (CD) is the key paediatric disorder characterized by severe aggression. It is heterogeneous, and our understanding of the neurobiology to subtype aggression is limited. MATRICS is a multidisciplinary consortium of academic partners and SMEs that focuses on the subtyping of aggression both within CD and of the broader cross-disorder trait of aggression. MATRICS will test the hypoth ...
Voir le projet

 21

 TERMINÉ 

Training the Next Generation of European Visual Neuroscientistsfor the benefit of innovation in health care and high-tech industry (NextGenVis)

Date du début: 1 mars 2015, Date de fin: 28 févr. 2019,

The human visual brain can learn and adapt to change, which solves many of the problems posed by an ever-changing visual environment. However, to maintain a consistent overall representation of the visual world, the brain also has to retain previously acquired neuronal mechanisms. The key is to strike a balance between plasticity and stability.Increasing our knowledge about the stability and plast ...
Voir le projet

 10

 TERMINÉ 

Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome (EpiPredict)

Date du début: 1 janv. 2015, Date de fin: 31 déc. 2018,

The mission of EpiPredict is to train a multidisciplinary cohort of young researchers in a new approach to fully exploit the epigenetics of complex diseases. The 12 early-stage researchers (ESRs) will focus on a narrowly defined case, Tamoxifen-induced resistance in Estrogen Receptor positive (ER+) breast cancer, considering five resistance interacting pathways. Given the frequent Tamoxifen treatm ...
Voir le projet

 8

 TERMINÉ 

Engineering of new-generation protein secretion systems (ProteinFactory)

Date du début: 1 janv. 2015, Date de fin: 31 déc. 2018,

The market for recombinant proteins, including biopharmaceuticals, industrial enzymes and membrane proteins, is estimated to be about 78 billion Euro and rising. A high proportion of the target proteins are produced in bacteria, where secretion out of the cytoplasm is a favoured strategy. However, current production platforms have severe limitations and cannot handle many secreted enzymes and memb ...
Voir le projet

 9

 TERMINÉ 

Models of Child Health Appraised (MOCHA)

Date du début: 1 juin 2015, Date de fin: 30 nov. 2018,

Children’s health affects the future of Europe – children are citizens, future workers, parents and carers. Children are dependent on society to provide effective health services (UN Convention on the Rights of the Child). Models of child primary health care vary widely across Europe based on two broad alternatives (primary care paediatricians or generic family doctors), and a variety of models of ...
Voir le projet

 20

 TERMINÉ 

Aggression subtyping for improved insight and treatment innovation in psychiatric disorders (AGGRESSOTYPE)

Date du début: 1 nov. 2013, Date de fin: 31 oct. 2018,

Aggression is a basic physiological trait with important roles throughout evolution, both in defence and predation. When expressed in humans in the wrong context, aggression leads to maladjustment, social impairment and crime. Despite this, knowledge about aggression aetiology is limited and current treatment strategies are insufficient. Contingent to a subdivision into impulsive and instrumental ...
Voir le projet

 27

 TERMINÉ 

RD-CONNECT: An integrated platform connecting registries, biobanks and clinical bioinformatics for rare disease research (RD-CONNECT)

Date du début: 1 nov. 2012, Date de fin: 31 oct. 2018,

Despite examples of excellent practice, rare disease (RD) research is still mainly fragmented by data and disease types. Individual efforts have little interoperability and almost no systematic connection between detailed clinical and genetic information, biomaterial availability or research/trial datasets. By developing robust mechanisms and standards for linking and exploiting these data, RD-Con ...
Voir le projet

 30

 TERMINÉ 

Free Respiratory Evaluation and Smoke-exposure reductionby primary Health cAre Integrated gRoups (FRESH AIR)

Date du début: 1 oct. 2015, Date de fin: 30 sept. 2018,

FRESH AIR is a 3 year project which addresses the urgent need to prevent, diagnose and treat lung diseases in LMICs and other low-resource settings where the greatest burden of disease is experienced. Our Consortium brings together leading international respiratory researchers, clinicians and policy experts from EU member states and the US who have expertise and experience of the challenges of imp ...
Voir le projet

 15

 TERMINÉ 

Translating disease to cardiovascular health (TransCard)

Date du début: 1 sept. 2013, Date de fin: 31 août 2018,

Cardiovascular disease (CVD) is the leading cause of death in Europe and the world. Drugs that lower cholesterol in blood are the most efficient drugs used to date but we are currently still facing a 50-70% residual risk of suffering from CVD. This clearly illustrates an urgent need for the identification, characterization and validation of novel therapeutically relevant targets. Over the last dec ...
Voir le projet

 8

 TERMINÉ 

WIE ARBEITEN WIR - WIE ARBEITET IHRGrenzen überschreiten - Denken und Handeln erweitern durch einen Einsatz in den Niederlanden

Date du début: 1 juil. 2016, Date de fin: 30 juin 2018,

The project „HOW DO WE WORK – HOW DO YOU WORK, Crossing borders – widening thinking and acting by service in the Netherlands“ arises from the productive collaboration with our partners for years. The plan to promote the nursing and vocational skills as well as the maturing and development of personality structures among participants across borders is monitored and supervised stringently. The objec ...
Voir le projet

 2

 TERMINÉ 

Consortium on Organ Preservation in Europe (COPE)

Date du début: 1 janv. 2013, Date de fin: 30 juin 2018,

The discrepancy between organ supply and demand remains the biggest challenge facing the transplant community today. In order to increase the amount of available donor organs, transplant specialists are increasingly turning to sub-optimal donor organs. Organs from such donors, usually have normal or near normal function before death, but retrieval, storage and transplantation cause progressive inj ...
Voir le projet

 16

 TERMINÉ 

European Consortium for Communicating Stem Cell Research (EuroStemCell)

Date du début: 1 janv. 2015, Date de fin: 31 mars 2018,

The European Consortium for Communicating Stem Cell Research (EuroStemCell) unites 33 partner institutions, that collectively represent >400 stem cell research groupings across Europe. Our common goal is to provide trusted high quality information on stem cells accessible to citizens and stakeholders across Europe, through support and further development of the multi-lingual European Stem Cell Inf ...
Voir le projet

 32

 TERMINÉ 

Personalized diagnosis and treatment of hyperinsulinemic hypoglycaemia caused by beta-cell pathology (BETACURE)

Date du début: 1 avr. 2014, Date de fin: 31 mars 2018,

Background:Hyperinsulinaemic hypoglycaemia (HH) is a potentially lethal disease caused by over functioning beta cells derived from the pancreatic islets of Langerhans. Lethal HH and brain damage is a problem especially in infants with congenital HH. Current therapeutic approaches are associated with severe side effects/morbidity (diabetes, exocrine pancreas insufficiency etc.) considered acceptabl ...
Voir le projet

 17

 TERMINÉ 

"Apathy in schizophrenia: time for a DRASTIC (Dual Routes to Apathy in Schizophrenia: Treatment, Imaging, Cognition) study" (DRASTIC)

Date du début: 1 avr. 2013, Date de fin: 31 mars 2018,

"Apathy is a prominent and severely debilitating aspect of several psychiatric disorders, most notably schizophrenia. Little is known regarding the neuroscientific basis of apathy, however. Clinically, it has been suggested that two forms of apathy can be distinguished: cognitive apathy (CA) which concerns reduced initiative to start daily activities and social-emotional apathy (SEA) which concern ...
Voir le projet

 1

 TERMINÉ 

Celiac disease: from lincRNAs to disease mechanism (CD-LINK)

Date du début: 1 févr. 2013, Date de fin: 31 janv. 2018,

"Celiac disease affects at least 1% of the world population. Its onset is triggered by gluten, a common dietary protein, however, its etiology is poorly understood. More than 80% of patients are not properly diagnosed and they therefore do not follow a gluten-free diet, thereby increasing their risk for disease-associated complications and early death. A better understanding of the disease biology ...
Voir le projet

 1